Cargando…
Participation in the nationwide cervical cancer screening programme in Denmark during the COVID-19 pandemic: An observational study
BACKGROUND: In contrast to most of the world, the cervical cancer screening programme continued in Denmark throughout the COVID-19 pandemic. We examined the cervical cancer screening participation during the pandemic in Denmark. METHODS: We included all women aged 23–64 y old invited to participate...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904756/ https://www.ncbi.nlm.nih.gov/pubmed/36661213 http://dx.doi.org/10.7554/eLife.81522 |
_version_ | 1784883684679090176 |
---|---|
author | Olesen, Tina Bech Jensen, Henry Møller, Henrik Jensen, Jens Winther Waldstrøm, Marianne Andersen, Berit |
author_facet | Olesen, Tina Bech Jensen, Henry Møller, Henrik Jensen, Jens Winther Waldstrøm, Marianne Andersen, Berit |
author_sort | Olesen, Tina Bech |
collection | PubMed |
description | BACKGROUND: In contrast to most of the world, the cervical cancer screening programme continued in Denmark throughout the COVID-19 pandemic. We examined the cervical cancer screening participation during the pandemic in Denmark. METHODS: We included all women aged 23–64 y old invited to participate in cervical cancer screening from 2015 to 2021 as registered in the Cervical Cancer Screening Database combined with population-wide registries. Using a generalised linear model, we estimated prevalence ratios (PRs) and 95% CIs of cervical cancer screening participation within 90, 180, and 365 d since invitation during the pandemic in comparison with the previous years adjusting for age, year, and month of invitation. RESULTS: Altogether, 2,220,000 invited women (in 1,466,353 individuals) were included in the study. Before the pandemic, 36% of invited women participated in screening within 90 d, 54% participated within 180 d, and 65% participated within 365 d. At the start of the pandemic, participation in cervical cancer screening within 90 d was lower (pre-lockdown PR = 0.58; 95% CI: 0.56–0.59 and first lockdown PR = 0.76; 95% CI: 0.75–0.77) compared with the previous years. A reduction in participation within 180 d was also seen during pre-lockdown (PR = 0.89; 95% CI: 0.88–0.90) and first lockdown (PR = 0.92; 95% CI: 0.91–0.93). Allowing for 365 d to participation, only a slight reduction (3%) in participation was seen with slightly lower participation in some groups (immigrants, low education, and low income). CONCLUSIONS: The overall participation in cervical cancer screening was reduced during the early phase of the pandemic. However, the decline almost diminished with longer follow-up time. FUNDING: The study was funded by the Danish Cancer Society Scientific Committee (grant number R321-A17417) and the Danish regions. |
format | Online Article Text |
id | pubmed-9904756 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-99047562023-02-08 Participation in the nationwide cervical cancer screening programme in Denmark during the COVID-19 pandemic: An observational study Olesen, Tina Bech Jensen, Henry Møller, Henrik Jensen, Jens Winther Waldstrøm, Marianne Andersen, Berit eLife Epidemiology and Global Health BACKGROUND: In contrast to most of the world, the cervical cancer screening programme continued in Denmark throughout the COVID-19 pandemic. We examined the cervical cancer screening participation during the pandemic in Denmark. METHODS: We included all women aged 23–64 y old invited to participate in cervical cancer screening from 2015 to 2021 as registered in the Cervical Cancer Screening Database combined with population-wide registries. Using a generalised linear model, we estimated prevalence ratios (PRs) and 95% CIs of cervical cancer screening participation within 90, 180, and 365 d since invitation during the pandemic in comparison with the previous years adjusting for age, year, and month of invitation. RESULTS: Altogether, 2,220,000 invited women (in 1,466,353 individuals) were included in the study. Before the pandemic, 36% of invited women participated in screening within 90 d, 54% participated within 180 d, and 65% participated within 365 d. At the start of the pandemic, participation in cervical cancer screening within 90 d was lower (pre-lockdown PR = 0.58; 95% CI: 0.56–0.59 and first lockdown PR = 0.76; 95% CI: 0.75–0.77) compared with the previous years. A reduction in participation within 180 d was also seen during pre-lockdown (PR = 0.89; 95% CI: 0.88–0.90) and first lockdown (PR = 0.92; 95% CI: 0.91–0.93). Allowing for 365 d to participation, only a slight reduction (3%) in participation was seen with slightly lower participation in some groups (immigrants, low education, and low income). CONCLUSIONS: The overall participation in cervical cancer screening was reduced during the early phase of the pandemic. However, the decline almost diminished with longer follow-up time. FUNDING: The study was funded by the Danish Cancer Society Scientific Committee (grant number R321-A17417) and the Danish regions. eLife Sciences Publications, Ltd 2023-01-20 /pmc/articles/PMC9904756/ /pubmed/36661213 http://dx.doi.org/10.7554/eLife.81522 Text en © 2023, Olesen et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Epidemiology and Global Health Olesen, Tina Bech Jensen, Henry Møller, Henrik Jensen, Jens Winther Waldstrøm, Marianne Andersen, Berit Participation in the nationwide cervical cancer screening programme in Denmark during the COVID-19 pandemic: An observational study |
title | Participation in the nationwide cervical cancer screening programme in Denmark during the COVID-19 pandemic: An observational study |
title_full | Participation in the nationwide cervical cancer screening programme in Denmark during the COVID-19 pandemic: An observational study |
title_fullStr | Participation in the nationwide cervical cancer screening programme in Denmark during the COVID-19 pandemic: An observational study |
title_full_unstemmed | Participation in the nationwide cervical cancer screening programme in Denmark during the COVID-19 pandemic: An observational study |
title_short | Participation in the nationwide cervical cancer screening programme in Denmark during the COVID-19 pandemic: An observational study |
title_sort | participation in the nationwide cervical cancer screening programme in denmark during the covid-19 pandemic: an observational study |
topic | Epidemiology and Global Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904756/ https://www.ncbi.nlm.nih.gov/pubmed/36661213 http://dx.doi.org/10.7554/eLife.81522 |
work_keys_str_mv | AT olesentinabech participationinthenationwidecervicalcancerscreeningprogrammeindenmarkduringthecovid19pandemicanobservationalstudy AT jensenhenry participationinthenationwidecervicalcancerscreeningprogrammeindenmarkduringthecovid19pandemicanobservationalstudy AT møllerhenrik participationinthenationwidecervicalcancerscreeningprogrammeindenmarkduringthecovid19pandemicanobservationalstudy AT jensenjenswinther participationinthenationwidecervicalcancerscreeningprogrammeindenmarkduringthecovid19pandemicanobservationalstudy AT waldstrømmarianne participationinthenationwidecervicalcancerscreeningprogrammeindenmarkduringthecovid19pandemicanobservationalstudy AT andersenberit participationinthenationwidecervicalcancerscreeningprogrammeindenmarkduringthecovid19pandemicanobservationalstudy |